Abstract: The autonomic nervous system exerts broad control over the involuntary functions of the human body through complex equilibrium between sympathetic and parasympathetic tone. Imbalance in this equilibrium is associated with a multitude of cardiovascular outcomes, including mortality. The cardiovascular static state of this equilibrium can be quantified using physiological parameters such as heart rate (HR), blood pressure, and by spectral analysis of HR variability. Here, we review the current state of knowledge of the genetic background of cardiovascular measurements of autonomic tone. For most parameters of autonomic tone, a large portion of variability is explained by genetic heritability. Many of the static parameters of autonomic tone have also been studied through candidate-gene approach, yielding some insight into how genotypes of adrenergic receptors affect variables such as HR. Genome-wide approaches in large cohorts similarly exist for static variables such as HR and blood pressure but less is known about the genetic background of the dynamic and more specific measurements, such as HR variability. Furthermore, because most autonomic measures are likely polygenic, pathway analyses and modeling of polygenic effects are critical. Future work will hopefully explain the control of autonomic tone and guide individualized therapeutic interventions.
INTRODUCTION
The autonomic nervous system (ANS) exerts intricate, nearly global control of all involuntary functions of the human body. Through reciprocal and cooperative activation of the 2 divisions of the ANS, the sympathetic and parasympathetic pathways, the ANS plays a critical role in homeostatic regulation. 1 In addition to regulating homeostasis, the ANS generates rapid hemodynamic and neuroendocrine responses to stressors. 2 Although the ANS regulates a diverse group of functions ranging from pupillary diameter to genitourinary function, 3 autonomic control of cardiovascular function has received increased interest. Autonomic function has been hypothesized to be central to the pathophysiology of heart failure, 4 hypertension, 5 and arrhythmias. 6, 7 Although aspects of autonomic function are heritable and may predispose individuals to disease states, 8 very little is known about the genetic underpinnings of autonomic function. With the development of affordable assays to measure not just the overall genetic contribution to physiological variables but also test for association with candidate genes or perform hypothesis-generating genome-wide association studies (Table 1) , the understanding of the genetic underpinning of autonomic function is gradually emerging. In this review, we outline the measurement of autonomic function, implications for disease pathogenesis, and the current state of knowledge regarding heritability and genetic determinants of autonomic function, with a focus on cardiovascular disease.
AUTONOMIC TONE: DEFINITION, MEASURE-MENT, HERITABILITY, AND USES AS PROGNOSTIC MARKERS
Defined simply, "autonomic tone" can be conceptualized as a rheostat balancing the 2 ANS divisions-the sympathetic and parasympathetic pathways. Although much of the autonomic nervous system trafficking is processed through reflex mechanisms, this likely omits a great deal of higher-order physiological complexity in autonomic regulation. 9 In the following section, we will outline a number of cardiovascular measures of autonomic tone, their utility as markers of health and disease, and available evidence regarding their heritability.
Heart Rate
Heart rate-the number of times per minute that the heart generates an electrical depolarization-is largely under control of the sinoatrial node, which is reciprocally regulated by autonomic effects on spontaneous diastolic depolarization.
In general, sympathetic stimulation results in an increase in heart rate (HR), whereas parasympathetic stimulation results in a decrease in HR. 10 Interestingly, although sympathetic stimulation shortens action potential duration (APD) in both ventricular and atrial myocardium, parasympathetic stimulation prolongs APD and effective refractory period (ERP) in the ventricles but shortens APD and ERP in the atria. This phenomenon may account for the fact that vagal stimulation is arrhythmogenic in the atria but antiarrhythmic in the ventricles. 6 Resting HR may serve as a potential marker of health and/or disease. In patients with cardiovascular disease, increased resting HR was associated with worsened cardiovascular outcomes. 11 In addition, increased resting HR was also predictive of incident heart failure in a population without known cardiac disease, 12 as well as all-cause mortality in individuals older than age 60. 13 Interestingly, increased resting HR is also associated with chronic orofacial pain. 14, 15 Conversely, a low-resting HR is associated with later development of atrial fibrillation. 16 Taken together, this suggests that shifts of autonomic tone toward sympathetic predominance may increase risk or progression of sympathetically mediated conditions, such as heart failure and chronic pain, whereas excessive parasympathetic tone may act as a trigger for atrial arrhythmias. Although age and sex differences exist in resting HR, 13 the genetic underpinnings of these differences remain unclear.
Heritability of Resting Heart Rate
Several authors have assessed the heritability of resting HR. A higher correlation was found between the resting HR of siblings than spouses of participants in the Framingham Heart Study. 17 Similarly, heritability was estimated to explain 40% of the variability in resting HR comparing related to unrelated individual in a study of Chinese and Japanese cohorts. 18 A study comparing ECG measurements between 251 pairs of twins found that heritability explained 77% of the variability in HR. 19 Similarly, a study comparing the correlation of both resting HR and HR after a mental calculation task between 372 pairs of monozygous and dizygous twins suggested that heritability explained about 63%-69% of the variability in both variables. 20 Candidate Gene Studies of Resting Heart Rate Several candidate genes have been suggested to affect resting HR, especially within the adrenergic receptors (Table 2) . A variant (Ser49Gly) within the beta-1 adrenergic receptor was found to be associated with resting HR in a cohort of 1348 Chinese/Japanese individuals. 18 The same variant was also associated with resting HR in hypertensive African-Americans and Caucasian individuals taking beta blockers in cohorts of 1337 and 1685 individuals, respectively. 21 Other variants of beta-1 receptors have additionally been associated with a differential response to beta-blocking therapy. 22 Other variants in the alpha-2 receptor were similarly associated with resting HR in subpopulations of Caucasian and African-American individuals. 21 
Genome-Wide Studies of Resting Heart Rate
Multiple genome-wide association studies have been performed on resting HR in several populations ( Table 2) . The first association identified through genome-wide association study (GWAS) of 2 populations with 10,000 individuals each was with rs365990, a missense variant in the myosin heavy chain alpha isoform (MYH6). 23 Later studies expanded the cohorts used in the original GWASs to include a total of 181,171 individuals. 24 These confirmed previous loci and added 14 additional loci, with loci also associated with dilated, hypertrophic and arrhythmogenic right ventricular cardiomyopathy, regulation of heart contraction, cell adhesion, energy metabolism, and Alzheimer's disease. Most recently, 64 loci, including 46 not previously described, were found to be significantly associated with resting HR in a study of 19.9 million variants in up to 265,046 individuals. 25 These included multiple loci on all but 3 autosomal chromosomes. Interestingly, none of the variants identified through GWAS approach include beta-adrenergic receptors, the focus of candidate approaches. This highlights the utility of using datadriven approaches to identify novel pathways associated with cardiovascular and autonomic phenotypes.
Blood Pressure, Systemic Vascular Resistance, and Baroreceptor Response
The autonomic nervous system exerts complex control over blood pressure through regulation of cardiac function, vascular resistance, intravascular volume, and integration of sensory inputs. 26 Short-term perturbations of blood pressure Blood pressure
Blood pressure
Blood pressure AGT Ehret et al GWAS rs2521501
Blood pressure KCNK3 Ehret et al GWAS rs2594992
Blood pressure HRH1-ATG7 Ehret et al GWAS rs2891546
Blood pressure TBX5-TBX3 Ehret et al GWAS rs2898290
Blood pressure BLK-GATA4 Ehret et al GWAS rs2969070
Blood pressure CHST12-LFNG Ehret et al GWAS rs3184504a
Blood pressure HOTTIP-EVX Ehret et al GWAS rs3741378a
Blood pressure SIPA1 Ehret et al GWAS Blood pressure
Blood pressure LSP1-TNNT3 Ehret et al GWAS rs6026748
Blood pressure GNAS-EDN3 Ehret et al GWAS rs6271a
Blood pressure DBH Ehret et al GWAS rs633185
Blood pressure FLJ32810-TMEM133 Ehret et al GWAS rs6442101a
Blood pressure MAP4 Ehret et al GWAS rs6779380
Blood pressure MECOM Ehret et al GWAS rs6891344
Blood pressure CSNK1G3 Ehret et al GWAS rs6919440
Blood pressure ZNF318-ABCC10 Ehret et al GWAS rs7076398
Blood pressure C10orf107 Ehret et al GWAS rs7103648
Blood pressure RAPSN Ehret et al GWAS rs711737
Blood pressure LRRC10B Ehret et al GWAS rs772178
Blood pressure ADAMTS9 Ehret et al GWAS rs932764a
Cold Heart rate KLHL42 Eppinga et al GWAS rs10739663
Heart rate MAPKAP1 Eppinga et al GWAS rs10841486
Heart rate PDE3A Eppinga et al GWAS rs10880689g
Heart rate ALG10B Eppinga et al GWAS rs11083258
Heart rate CDH2 Eppinga et al GWAS rs11118555
Heart rate CD46 den Hoed et al GWAS rs11454451
Heart rate GPATCH2 Eppinga et al GWAS (continued on next page ) Heart rate CCDC58 Eppinga et al GWAS rs12501032
Heart rate PPARGC1A Eppinga et al GWAS rs12576326
Heart rate TP53I11 Eppinga et al GWAS rs12579753
Heart rate PPFIA2 Eppinga et al GWAS rs1260326
Heart rate GCKR Eppinga et al GWAS rs12713404
Heart rate BCL11A Eppinga et al GWAS rs12721051
Heart rate APOE; APOC1; PVRL2 Eppinga et al GWAS rs12889267
Heart rate NDRG2; ARHGEF40; ZNF219 Eppinga et al GWAS rs13165531
Heart rate CDH6 Eppinga et al GWAS rs138186803
Heart rate MKLN1 Eppinga et al GWAS rs145358377
Heart rate RNF207; ICMT Eppinga et al GWAS rs1468333f
Heart rate CDC23 Eppinga et al GWAS rs1483890
Heart rate FRMD4B Eppinga et al GWAS rs1549118
Heart rate ADCK1 Eppinga et al GWAS rs16974196
Heart rate C19orf47; MAP3K10 Eppinga et al GWAS rs17180489
Heart rate RGS6 Eppinga et al GWAS rs17265513
Heart rate ZHX3; EMILIN3 Eppinga et al GWAS rs1801252
Heart rate ADRB1
Heart rate SUN2; CBY1; FAM227A; JOSD1; TOMM22; DDX17; GTPBP1
Eppinga et al GWAS rs2152735
Heart rate LMO4 Eppinga et al GWAS rs2283274
Heart rate CACNA1C Eppinga et al GWAS rs2358740
Heart rate CACNA1D Eppinga et al GWAS rs236349
Heart rate PPIL1 Eppinga et al GWAS rs272564
Heart rate RNF220 Eppinga et al GWAS rs365990
Heart rate MYH6 Holm et al GWAS rs3749237
Heart rate IP6K1; GMPPB; FAM212A; DAG1; KLHDC8B; LAMB2; PRKAR2A; QRICH1
Eppinga et al GWAS rs3915499
Heart rate MYH11 Eppinga et al GWAS rs41312411
Heart rate SCN5A Eppinga et al GWAS rs41748
Heart rate MET Eppinga et al GWAS rs4608502
Heart rate COL4A3 Eppinga et al GWAS rs4900069
Heart rate C14orf159 Eppinga et al GWAS rs56233017
Heart rate PLEC Eppinga et al GWAS rs564190295
Heart rate WIPF1 Eppinga et al GWAS rs58437978
Heart rate TBX20 Eppinga et al GWAS rs61735998
Heart rate FHOD3 Eppinga et al GWAS rs6845865
Heart rate ARHGAP10; EDNRA Eppinga et al GWAS rs7194801
Heart rate CDH11 Eppinga et al GWAS rs75190942
Heart rate KCNJ5; C11orf45 Eppinga et al GWAS rs79121763
Heart rate TEKT3; PMP22 Eppinga et al GWAS rs867400
Heart rate RASSF3 Eppinga et al GWAS rs907683
Heart rate SPEG; DES Eppinga et al GWAS rsl015451
Heart rate GJA1 den Hoed et al GWAS rsl3245899
Heart rate ACHE den Hoed et al GWAS rsl7287293
Heart rate LINC00477 (C12orf67) den Hoed et al GWAS rsl74549
Heart rate FADS1 den Hoed et al GWAS rs11153730
Heart rate SLC35F1 den Hoed et al GWAS rs12974991, rs12974440, rs12980262
Heart rate variability NDUFA11 Nolte et al GWAS rs10842383
Heart rate variability LINC00477 (C12orf67) Nolte et al GWAS are sensed in large part by arterial baroreceptors, which then modulate efferent sympathetic and parasympathetic trafficking. Although chronotropic responses to changes in blood pressure largely rely on the parasympathetic nervous system, the sympathetic nervous system exercises greater control over peripheral vascular tone and cardiac function. 27 Indeed, neurodegenerative disorders affecting the sympathetic nervous system often result in symptomatic hypotension because of failure of part of the baroreceptor reflex arc. 28 The role of the sympathetic nervous system in chronic blood pressure elevation is well appreciated, with numerous studies demonstrating sympathetic hyperactivity in patients with both early and established hypertension. 29 Indeed, many pharmacologic treatments for hypertension aim to reduce the sympathetic hyperactivity that is believed to play a central role in the pathogenesis of hypertension. 30 In addition, emerging nonpharmacologic strategies for the management of hypertension include modulation of sympathetic tone. 27 The role of blood pressure as a marker of health and disease is well established. Orthostatic hypotension is associated with a higher risk of incident stroke and coronary artery disease. 31 Similarly, failure to appropriately augment blood pressure in response to physical exercise is associated with higher cardiovascular morbidity and mortality. 32 Hypertension-elevated resting blood pressure-is an extremely common medical condition that increases risk of stroke, myocardial infarction, heart failure, and renal disease. 33 To mitigate these risks, current guidelines recommend careful treatment of hypertension, 34 although recent trials might result in changes in target blood pressure. 35 Evidence suggests that sex and race may impact adrenergic receptor responsiveness, thereby mediating vascular resistance. 36 
Heritability of Resting Blood Pressure, Systemic Vascular Resistance, and Baroreceptor Response
Heritability in measurements of both systolic blood pressure (SBP) and diastolic blood pressure (DBP) has been established, with the correlation of both resting BP and BP responses to a mental stressor (mental arithmetic) using twin pairs, revealed that 49%-72% of the variability in DBP and SBP was explained by heritability. 20 Similarly, using a highdensity single-nucleotide polymorphism (SNP) genotyping in 2 large cohorts, 20%-27% and 39%-50% of the variability in SBP and DBP, was explained by heritability. 37 In a family study with 444 individuals, both 23% of blood pressure and 39% variability in pulse pressure were found to be explained by heritability. 38 In 172 pairs of twins using a noninvasive measurement of cardiac output, the heritability of systemic vascular resistance was found to be 59%. 39 Finally, heritability explained 36%-44% of the variability in measurements of baroreceptor sensitivity, measured as the slope between instantaneous blood pressure and subsequent R-R interval in a study of 149 twin pairs. 40 
Candidate Gene Studies of Resting Blood Pressure
Few authors have attempted association of plausible candidates to blood pressure variation (Table 2) . Screening individuals from the Framingham heart study for variants in genes associated with salt handling known to cause familial hypertension or hypotension (SLC12A3, SLC12AI, and KCNJ1), 138 coding sequence variants were identified in 2492 individuals. 41 Individuals carrying the rare variants had a significantly lower SBP than individuals without them. In addition, variants within 160 genes with a biological link to hypertension were assessed for association with measurements of blood pressure in 3 cohorts, revealing only a weak association for variants with 2 of the genes (LEPR and ADRA2A) and blood pressure. 42 There was only a weak association between homozygotes for variants in the Rho/rho kinase isoform 2 gene (ROCK2) and systemic vascular resistance. 39 Baroreceptor reflex, measured as the blood pressure response to a Valsalva maneuver, differed between variants in the aldosterone synthase (CYP11B2). 22 Another study, quantifying baroreceptor reflex sensitivity by measuring the fluctuation between systemic blood pressure and R-R interval, also identified association between the response and variants in the CYP11B2 gene and both the bradykinin B2 receptor (BDKRB2) and the endothelial nitrous oxide (NOS3) synthase gene. 43 
Genome-Wide Studies of Blood Pressure
Original genome-wide approaches in a sample of 14,000 individuals identified no genetic regions associated with a diagnosis of hypertension. 44 Increasing the number of patients by combining multiple large consortia of individuals has subsequently identified more than 60 loci associated with quantitative measurements of blood pressure, each with a relatively small contribution to the phenotype (Table 2) . [45] [46] [47] This highlights the challenges in mapping and understanding how very complex genetic interactions contribute to blood pressure regulation.
Heart Rate Variability
As one of the primary controllers of HR, the autonomic nervous system plays a large role in dictating the length of the interbeat interval-the length of time between each heartbeat. These beat-to-beat fluctuations in HR can be measured with a variety of technologies and interpreted over short (ie, 5 minutes) or long (ie, 24 hours) periods. Short recordings are typically analyzed using frequency-domain measures, which group interbeat fluctuations into several defined frequency spectra of high frequency (HF), low frequency (LF), and very low frequency (Fig. 1A) . In addition, normalized measurements of high frequency (HF/HF + LF), low frequency (LF/ HF + LF), and ratio of LF/HF have been used as surrogate markers of autonomic tone. The quantification of the fluctuation within each frequency spectra can then be used for analysis of the genetic background of autonomic tone (Fig.  1B) . Similarly, long recordings of interbeat intervals may be analyzed using frequency-domain or time-domain techniques, which quantitatively describe the variability as normalnormal intervals. 48 The variability is then traditionally described as SD of normal-normal interval (SDNN), root mean square of successive differences (RMSSDs), and percentage of successive intervals with more than 50 ms difference (pNN50). In addition, multiple novel analytic techniques, which are beyond the scope of this review, may provide insight into autonomic tone. 49 In both healthy FIGURE 1. Example of the analysis of the genetic background of heart rate variability: A, RR interval (time between heart beats) is collected over 5 minutes, and spectral analysis performed by fast Fourier transform of the signal to describe the data in domains of HF, LF, very low frequency (VLF), and LF/HF ratio. B, The quantified measurements of heart rate variables are then compared between different genotypes of candidate genes or different alleles of single nucleotide polymorphisms evenly distributed throughout the genome in an unbiased genome-wide approach.
controls 50 and patients with risk factors for cardiovascular disease, 51 levels of adrenergic hormones correlate with frequency-domain measures of heart rate variability (HRV). Similarly, cardiac norepinephrine spillover correlates with nonlinear measures of HRV complexity. 52 Analysis of HR variability may provide valuable insights in a variety of settings. 53 Multiple studies have suggested that decreased HR variability may predict worsened outcomes in patients with congestive heart failure or after acute myocardial infarction. 54 Frequency-domain measures of HRV predict dysrhythmias in both ambulatory patients 16, 55 and patients after major thoracic surgery. 56 In patients with chronic pain 57 and chronic headaches, 58 frequency-domain measures of HRV suggest decreased vagal function compared with healthy controls. In addition, reduced HR complexity is predictive of mortality in both critically ill patients 59 and trauma patients, regardless of injury mechanism. 60 Interestingly, sex and ethnic differences exist in frequency-domain measures of HRV, 61 although the genetic underpinnings of these differences remain unclear.
Another tool used to assess baroreceptor sensitivity is HR turbulence, which measures the variability in the beat-tobeat duration after a single premature ventricular beat. 62 This variable is believed to reflect the reflex activation of the vagus nerve to control sinus rhythm. 63 Several studies have associated HR turbulence with morbidity from cardiovascular diseases. 64, 65 This could partially be due to differences in intrinsic cardiac innervation during electrical remodeling of diseased myocardium, as well as mediated through autonomic influences on ion channels contributing to arrhythmogenesis. 62 
Heritability of Heart Rate Variability
A substudy of the Framingham heart study found a higher correlation in several measurements of HRV between siblings than spouses of individuals included in the study, indicating a genetic contribution to the parameter. 17 Similarly, the twin heart study found that there was a higher correlation between indices of HRV between monozygous twins than heterozygous twins. 66 Ambulatory HRV, assessed at 4 periods in the day by SDNN and RMSSD from 24 hours ECG measurements, has also been compared between monozygous twins and dizygous twins/singleton siblings in a study of 772 individuals. 67 The genetic contribution to ambulatory HRV ranged from 35% to 48%. Recently, the heritability of multiple indices of HRV (HR, SDNN, RMSSD, pNN50, LF, HF, and LF/HF) was assessed in a large sample of 1060 adult twins, revealing that heritability explained approximately 50%-60% of the variability of all HRV measurements performed. 68 This indicates that a portion of interindividual variability in HRV is mediated by shared genome rather than shared environment.
Candidate-Gene Approaches
Several studies have attempted to associate variants in individual genes or regions with measurements of HRV, mostly variants within the acetylcholinergic pathway. A study identified an association between a variant in the choline transporter gene (SLC5A7) and HRV assessed by both LF power and LF/HF ratio. 69 Variants in the brain-derived neurotrophic factor were associated with both HF power and LF/ HF ratio in a sample of 211 Chinese Han individuals. 70 The largest study to date combined genetic and HRV information for 6740 individuals from 7 smaller studies into discovery and replication cohorts and then tested for association of 443 variants within genes related to acetylcholine pathway (CHAT, SLC18A3, SLC5A7, CHRNB4, CHRNA3, CHRNA, CHRM2, and ACHE) and measurements of HRV assessed by RMSSD. 71 After correcting for multiple testing, no variant was found to be associated with HRV. The authors suggested that although acetylcholine pathways might be involved in the physiology of HRV, their epigenetic interactions with other pathways controlled by other genes might not be fully understood. Identifying genes and pathways associated with HRV, therefore, likely requires an unbiased high-resolution genome-wide approach in an adequately powered cohort with high-quality HRV phenotypes coupled with new and emerging bioinformatic and statistical procedures that permit the examination of gene-gene interactions.
Genome-Wide Association Studies
The first attempted genome-wide scan for HRVassociated traits was a linkage scan of individuals from the Framingham Heart Study, associating genetic regions with measurements of HRV (very low frequency power, LF power, and HF power). 72 This identified 2 genetic regions on chromosomes 2 and 15. The region on chromosome 15 is in proximity with a cluster of genes coding for the nicotinic acetylcholine receptor. However, a follow-up 100-kb SNP resolution genome-wide scan of HRV (assessed by LF/HF power and total power) did not identify any variants associated with HRV in a cohort of 548 individuals from the offspring substudy of the Framingham study. 73 A recent meta-analysis using 17 genome-wide association studies assessed the genetic contribution to HRV. 74 This was performed mostly through studies measuring interbeat interval variability (SDNN and RMSSD) on short or ultra-short (10 seconds) ECGs, although these variability measurements are more traditionally performed on ECG measurements of longer duration. This study identified that genetic risk scores by combination of risk alleles only predicted 0.9%-2.6% of the variability in these measurement but also identified 8 loci with genome-wide associations. As expected, there was a strong association between these measurements of HRV and HR, and several loci associated with HR were identified. These include pathways affecting acetylcholine release in the sinoatrial node and genes coding for muscarinic adrenergic potassium channels (GIRK). 74 
Lessons From Monogenic Diseases Affecting Cardiovascular Tone
Several monogenic diseases have shed light on potential mechanisms affecting cardiovascular presentation of autonomic tone. Patients with dopamine beta-hydroxylase deficiency suffer from severe orthostatic hypotension in addition to other symptoms of lack of sympathetic tone, such as hypothermia. 75 The disease is due to mutations in the dopamine beta-hydroxylase (DBH) gene responsible for conversion of dopamine to norepinephrine. 75 Similarly, patients with mutations in the norepinephrine-transporter gene (NET/SLC6A2) impairing the reuptake of norepinephrine into the releasing neuron. This results in increased activity and spillage of norepinephrine into circulation, resulting in elevated baseline HR and a profound response to orthostatic challenge. 76 Pathogenic mutations affecting the expression or increased copy numbers of the Parkinson's disease 1 or 4 gene (SNCA, PARK1, and PARK4) result in abnormally high expression of the alpha-synuclein protein, interacting with dopamine metabolism and affecting downstream generation of noradrenaline. In addition to causing early-onset Parkinson's disease, these patients will frequently have dysregulation in peripheral adrenergic receptors and symptoms of severe orthostatic hypotension. 77 These diseases all highlight the importance of metabolism of adrenergic neurotransmitters in modulating autonomic cardiovascular tone.
Autonomic Response to Physical Stress Heritability of Autonomic Response to Physical Stress
Compared with the available data on heritability and the genetic background of HR, BP, and HRV, less is known about the response to physical stressors. Several studies have tested the heritability of blood pressure response to orthostatic challenge, such as a head-up table tilting, which is the most commonly applied physical stress. The heritability of blood pressure response to head-up table test was compared in a cohort of 444 individuals from 5 multigenerational families. 38 Heritability was assumed to explain about 14%-19% of the variability in the DBP and SBP response to the head-up table test. Similarly, heritability was estimated to explain 25% of the change in SBP from an orthostatic challenge in a cohort of 767 families. 78 A total of 40% of the variability in HR change in response to cold pressor test were found to be heritable in a study of 576 individuals from twin and sibling pairs. 79 Another study found that 12%-25% of the blood pressure response to cold pressor test was due to genetic effects in a family cohort of 835 individuals. 80 
Candidate Gene Studies of Autonomic Response to Physical Stress
In a cohort of 3630 untreated hypertensive patients, individuals homozygous for the Arg389/Gly variant in the beta-1 adrenergic receptor were found to have a greater change in SBP after an orthostatic challenge. 81 Polymorphisms in GNAS1, another gene in the sympathetic nervous system, were also found to be associated with differential response to orthostatic challenge in a cohort of 415 individuals. 82 No association was found with variants within genes involved in the renin-angiotension-aldosterone pathway. A weak association between orthostatism and a variant in the NEDD4L gene, that regulates expression of a sodium channel in the kidney, was also found in a study of 793 individuals. 83 Variants in the EBF1 and CYP17A1 genes were associated with a diagnosis of orthostatic hypotension in a study that tested the association of 31 variants associated with blood pressure or hypertension in genome-wide analysis in cohort of 38,970 individuals from 5 populations. 84 Multiple variants within sympathetic pathway have been associated with differential response to the cold pressor test (Table 2) . Among those are variants in the CYB561 gene, a transporter gene in the sympathetic pathway, 79 as well as variants in the tyrosine hydroxylase (TH) gene, involved in catecholamine biosynthesis. 85 Polymorphism in the beta-2 adrenergic receptor was also associated with the blood pressure response in a cohort of young twins. 86 Furthermore, genes involved in intracellular signal transduction and its response to salt load, namely ADD1 and GNB3, and in genes (AGT, AGTR1) within renin-angiotensin-aldosterone pathway were also associated with the response to the cold pressor test in a Chinese Han population. 87, 88 Genome-Wide Association Studies of Autonomic Response to Physical Stress A genome-wide study of changes in hypertension with orthostatic challenge in 2 Korean populations totaling approximately 6000 individuals identified multiple variants within the CTNNA2 gene, previously unassociated with any autonomic phenotypes, and changes in SBP. 89 Variants in PIK3AP1 were also associated with changes in SBP and variants in ACTBL2, STAR, and MYLK4 were associated with changes in DBP. None of these variants have been previously associated with autonomic tone. No variant was associated with a diagnosis of orthostatic hypotension. A genome-wide linkage study followed by SNP screen of linked regions identified variants in the MCM8, SLC23A2, and STK35 genes associated with the blood pressure response to the cold pressor test, through unknown pathways. 90 
Autonomic Response to Mental Stress
The heritability of the hemodynamic response to mental stressors has been assessed. In addition to baseline measurements, heritability was found to explain 44%-74% of the HR and BP response to both a reaction time task and calculation task in a twin study with 373 twin pairs. 20 Another study found no significant increase in heritability in the response of HF and RMSSD measurements of HRV when 735 twin pairs were exposed to virtual reality-driving stressor, video game, or a social competence interview. This indicates that the same genes regulate the HRV under rest and stress. 91 However, a subset of the individuals also underwent 24 hours of blood pressure measurement to assess hemodynamic response to real-life stressors. This indicated that a substantial fraction of the variability in hemodynamic response was unexplained by genes explaining baseline HRV. 92 Thus far, no candidate-gene studies or genome-wide association studies on the hemodynamic effects of mental stress exist.
CONCLUSIONS AND FUTURE DIRECTIONS
Autonomic tone is a paramount physiological variable associated with multiple cardiovascular outcomes of clinical interest. Cardiovascular measures of autonomic tone involve both basic measurements of the static components such as HR and blood pressure as well as more complex measurements of the dynamic components of autonomic tone such as different spectra of HR variability. Furthermore, the effects of physiological and psychological strain on these measurements can be quantified.
Both the heritability and genetic background of the static aspects of cardiovascular measurements of autonomic tone, such as resting HR and blood pressure, have been thoroughly studied. As highlighted here, this has revealed a substantial genetic component of these static variables, both when studied macroscopically by shared variability between twins and in highresolution genome-wide association studies. Interestingly, there is no overlap where associations between these measurements and plausible candidate genes identified through candidate-gene studies have not been identified or confirmed in a hypothesisfree genome-wide association studies. Furthermore, the identified variants generally did not conform to a single cellular signaling or metabolic pathway. This indicates that there is likely a multifactorial genetic contribution to these variables.
Furthermore, heritability represents a large component of the variability in measurements of the dynamic phase of autonomic tone, namely HR variability and changes in HR, blood pressure, and HR variability with physical and psychological stressors. However, there is currently a lack of high-resolution genome-wide association studies with a high-quality phenotyping of these important variables. Furthermore, novel bioinformatical methods, such as functional group/pathway analysis and modeling of polygenic effects, should be applied to the results of genome-wide association analyses to reveal effects that are not able to pass conservative significance thresholds typically applied to the genome-wide analyses. Comprehensive functional annotation of genetic variants through bioinformatic databases (such as tissue-specific gene expression and DNA methylation maps) is needed to understand how identified variants mediate their biological effects. Finally, limited work exists on modification of autonomic tone to affect the associated cardiovascular outcomes. These could include HR modulation by blockade of beta receptor or calcium channels. It is likely that only a subset of the patients would have benefit from such interventions, and perhaps these patients could be identified in the future from their genetic background. It is likely that such studies will follow, given the utility of such information for cardiovascular risk prognostication and development of novel therapeutics.
